Education
About Us
Working with TipRanks
Follow Us
Apogee Therapeutics (APGE)
NASDAQ:APGE
RESEARCH TOOLSreports
| Dec 23 | Dec 22 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 |
| Operating Income | $ -93.00M | $ -30.73M |
| EBITDA | $ -83.98M | $ 0.00 |
| Net Income | $ -83.98M | $ -39.78M |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ 395.46M | $ 151.89M |
| Total Assets | $ 401.40M | $ 152.06M |
| Total Debt | $ 2.03M | $ 0.00 |
| Net Debt | $ -116.28M | $ -151.89M |
| Total Liabilities | $ 21.49M | $ 9.98M |
| Stockholders' Equity | $ 379.91M | $ -39.78M |
| Cash Flow | ||
| Free Cash Flow | $ -74.93M | $ -16.43M |
| Operating Cash Flow | $ -74.76M | $ -16.43M |
| Investing Cash Flow | $ -273.91M | $ 0.00 |
| Financing Cash Flow | $ 315.39M | $ 183.62K |